Biomedical Research Institute of New Mexico
12
2
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
33%
4 trials in Phase 3/4
43%
3 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Bempedoic Acid Therapy for Polycystic Kidney Disease
Role: collaborator
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
Role: collaborator
Long-term Effectiveness of the Antiobesity Medication Phentermine
Role: collaborator
Pain and Opioids: Integrated Treatment In Veterans
Role: collaborator
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
Role: collaborator
Lifestyle Intervention to Improve Bone Quality
Role: collaborator
High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for Sensory Deficits in Complex Traumatic Brain Injury
Role: collaborator
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Role: collaborator
Lifestyle Intervention and Testosterone Replacement in Obese Seniors
Role: collaborator
Lifestyle Intervention for Senior Diabetics
Role: collaborator
Lifestyle Intervention Trial in Obese Elderly
Role: lead
Impact of Accu-Chek 360 in Veterans With Type 2 Diabetes
Role: lead
All 12 trials loaded